期刊文献+

射波刀治疗计划准直器对剂量分布和治疗时间影响的研究 被引量:6

Research on collimators on dose distribution and treatment time of Cyber Knife treatment planning
下载PDF
导出
摘要 目的:研究不同规格准直器对剂量分布和治疗时间的影响,为射波刀治疗计划设计中准直器的选择提供参考和指导。方法:分别使用12种规格的准直器对3个大小不同的肿瘤靶区进行计划设计,得出每个靶区在不同准直器下对应的剂量分布和治疗时间,并分析其存在的关系。结果:随着准直器尺寸的增加,治疗时间变得越来越少;当准直器尺寸远大于靶区时,剂量分布随准直器尺寸增加变得越好,但是正常组织受到的照射剂量越多。结论:在治疗计划设计中准直器尺寸的选择应比肿瘤尺寸略小,约占肿瘤直径的2/3,准直器的选择可为肿瘤治疗提供参考依据,并具有重要的指导意义。 Objective:To study the effect of different sizes of collimators on dose distribution and treatment time, and provide the reference of selecting collimators for planning design. Methods:To design the planning by using collimators with 12 kinds of size for three different size tumors, and analysis the dose distribution and treatment time of planning with different collimators. Results:The treatment time is becoming less and less with increasing of the collimator size;the dose distribution becomes better and better when collimator size becomes large, but the dose of the normal tissue becomes more. Conclusion: The selection of collimator size may be smaller than tumor size by analyzing the results of three groups, and about 2/3 of tumor diameter, which provides important reference and guidance significance for designing the treatment planning with choosing collimators.
出处 《中国医学装备》 2015年第10期39-42,共4页 China Medical Equipment
关键词 射波刀 准直器 剂量分布 CyberKnife Collimator Dose distribution
  • 相关文献

参考文献16

  • 1Nomura Suzuki I. CyberKnife radiosurgery-present status and future prospect[J]. BrainNerve ,2011,63 (3):195-202.
  • 2Dieterich S,Gibbs IC. The CyberKnife inclinical use: current roles,future expectations[J].Front Radiat Ther Oncol,2011,43: 181-194.
  • 3Janv^ry Z,Jansen N,Coucke P.The CyberKnifeas a perfect tool for new therapeutic challenges inradiotherapy[J]. Rev Med Liege, 2014,69(S 1) . 87-93.
  • 4Chen Guang-yao. CyberKnife radiosurgerytreatment standard guidelines[M]. Shanghai : XuelinPress, 2008.
  • 5Coste-Maniere E,01ender D,Kilby W,et al.Roboticwhole body stereotactic radiosurgery : clinicaladvantages of the CyberKnife integrated system[J] .Int J Med Robot,2005, 1(2):28-39.
  • 6Yamazaki H,Ogita M,Himei K,et al.Hypofrac-tionated stereotactic radiotherapy usingCyberKnife as a boost treatment for head andneck cancer,a multi-institutional survey:impactof planning target volume[J]. AnticancerRes, 2014,34(10):5755-5759.
  • 7Bonomo P, Cipressi S,Iermano C ,et al.Salvage stereotactic re-irradiation with CyberKnifefor locally recurrent head and neck cancer:a singlecenter experiencefJ]. Tumori, 2014,100(3): 278-283.
  • 8Olson AC,Wegner RE,Rwigema JC,et al.Clinical outcomes of reirradiation of brainmetastases from small cell lung cancer withCyberknife stereotactic radiosurgery[J]. J CancerResTher,2012,8(3):411-416.
  • 9Yang G,Wang Y,Wang Y,et al.CyberKnifetherapy of 24 multiple brain metastases from lungcancer:A case report[J].Oncol Lett,2013,6(2):534-536.
  • 10Yang G,Li M,Wang Y,et al.Successful treatmentof non-small cell lung tumor with 15 lesions byCyberKnife radiosurgery:A case report[J].ExpTher Med,2013,6(3):808-810.

二级参考文献44

  • 1陈光耀.临床肿瘤医师如何善用放射外科的新利器[J].中国肿瘤临床,2007,34(1):1-5. 被引量:16
  • 2GOLDSTEIN D, VAN HAZEL G, WALPOLE E, et al. Gemcitabine with a specific conformal 3D 5-FU radiochemotherapy technique is safe and effective in the definitive management of locally advanced pancreatic cancer [ J ] . BrJ Cancer, 2007, 97(4): 464-471.
  • 3CASTELLI J, THARIAT J, BENEZERY K,et al. Feasibility and efficacy of CyberKnife radiotherapy for lung cancer: early results [ J ] . Cancer Radiother, 2008, 12(8): 793-799.
  • 4BROWN W T, WU X, FAYAD F, et al. CyberKnife radiosurgery for stage I lung cancer: results at 36 months [ J ] . Clin Lung Cancer, 2007, 8(8): 488-492.
  • 5VAN DER VOORT VAN ZYP N C, PRIVOST J B, HOOGEMAN M S, et al. Stereotactic radiotherapy with real- time tumor tracking for non-small cell lung cancer: clinical outcome [ J . Radiother Oncol, 2009, 91(3): 296-300.
  • 6GHANEHP,KAWESHAA,HOWESN,eta1.Adjuvanttherapyforpancreaticcancer[J].WordJSurg,1999,23(9):937-945.
  • 7COSTE-MANIERE E, OLENDER D, KILBY W, et al. Robotic whole body stereotactic radiosurgery: clinical advantages of the CyberKnife integrated system [ J 1 Int J Med Robot, 2005, 1(2): 29-39.
  • 8YU G, JOZSEF G, APUZZO M L, et al. Measurementis of the relative output factors for CyberKnife collimators [ J . Neurosurgery, 2004, 54(1): 157-161.
  • 9KOONGA C, LE Q T, HO A, et al. Phase | study of stereotactic radiosurgery in patients with |ocally advanced pancreatic cancer [ J ] . Int J Radiat Oncol BioI Phys, 2004, 58(4): 1017-1021.
  • 10KOONG A C, CHRISTOFERSON E, LE Q T, et al. Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer [ J ] . Int J Radiat Oncol Bio Phys, 2005, 63(2): 320-323.

共引文献24

同被引文献33

引证文献6

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部